- Home
- ATO vs RVMD Comparison
ATO vs RVMD Comparison
Compare ATO & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATO | RVMD |
|---|---|---|
| Founded | 1906 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.8B | 30.1B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ATO | RVMD |
|---|---|---|
| Price | $162.75 | $201.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 19 |
| Target Price | ★ $182.25 | $140.84 |
| AVG Volume (30 Days) | 787.5K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 9.22 | N/A |
| EPS | ★ 7.33 | N/A |
| Revenue | ★ $4,702,755,000.00 | N/A |
| Revenue This Year | $15.32 | N/A |
| Revenue Next Year | $10.09 | $533.02 |
| P/E Ratio | $22.11 | ★ N/A |
| Revenue Growth | ★ 12.91 | N/A |
| 52 Week Low | $160.10 | $42.18 |
| 52 Week High | $192.51 | $224.31 |
Technical Indicators
Market Signals| Indicator | ATO | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 31.70 | 49.76 |
| Support Level | N/A | $198.91 |
| Resistance Level | $171.26 | $222.33 |
| Average True Range (ATR) | 2.28 | 8.26 |
| MACD | -0.35 | -1.73 |
| Stochastic Oscillator | 0.65 | 26.60 |
Price Performance
Historical ComparisonAbout ATO Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3.3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.